During the past decade, Southeastern Research Center conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 10 clinical trials were completed. i.e. 52.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Research Center" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Antiva Biosciences" with 2 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored, "Bellus Health Inc" with 2 trials sponsored and "Biodesix, Inc." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Research Center" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "HealthCore-NERI" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Research Center" are "Idiopathic Pulmonary Fibrosis" (6 trials), "Chronic Obstructive Pulmonary Disease" (4 trials), "Pulmonary Disease, Chronic Obstructive" (3 trials), "Alpha1-antitrypsin Deficiency" (2 trials) and "COPD" (2 trials). Many other conditions were trialed in "Southeastern Research Center" in a lesser frequency.

Most popular intervention types in "Southeastern Research Center" are "Drug" (28 trials), "Biological" (3 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "BI 1015550" (3 trials), "ABI-1968" (2 trials), "BLU-5937" (2 trials) and "SUN-101 50 mcg BID eFlow (CS) nebulizer" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Research Center" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Southeastern Research Center". undefined are not yet recruiting, 13 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Southeastern Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Research Center, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".